Panacea Biotec has filed a suit before the Delhi High Court seeking to restrain Sanofi Healthcare India from marketing a fully liquid hexavalent vaccine. A case has been filed in order to stop infringement of its patent for fully liquid whole cell pertussis based fully liquid Hexavalent vaccine EasySix.
Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.